West Bengal reports 26 more Covid-19 cases, 2 babies admitted to Kolkata hospital
According to sources from the health department, two infants, a three-month-old and a one-year-old, have been admitted to a private hospital on Eastern Metropolitan Bypass. The babies were brought in for check-ups due to high fever, cough, and cold symptoms. Suspecting Covid-19, the doctor conducted tests, which returned positive results, leading to their admission to the hospital.
Counters for Covid testing have been opened at Calcutta Medical College and Hospital. Sources in the health department have reported that a report has been sent to the Centre detailing the actions taken by the state, the number of patients currently admitted to the hospital, and their present conditions.
At the beginning of May, Kolkata had only one Covid-19 case. However, by the end of the month, there was a rapid increase in the number of cases. There has also been one death in the state due to the virus.
According to sources in the hospitals, although the Covid symptoms are mild, the rising number of cases has led hospitals to increase the number of Covid beds in private facilities.
While the health department has not yet issued any health advisory, the Kolkata Municipal Corporation (KMC) has decided to raise awareness about the importance of taking precautionary measures.
The KMC is set to display banners in all its health units across the city, encouraging people to wash their hands, wear masks, and maintain social distancing. Health workers in every ward have been instructed to gather information on Covid-19 symptoms in addition to their regular data collection related to malaria and dengue.
They have also been advised to isolate any individuals exhibiting influenza-like symptoms or severe acute respiratory symptoms (SARI). With the rise in Covid-19 cases and heightened surveillance, health department sources report that two isolation wards have been prepared at ID Hospital in anticipation of a potential increase in cases.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
7 hours ago
- Time of India
AIOCD demands strict action against illegal e-pharmacies; raises alarm over inaction by SLAs
The All-India Organisation of Chemists and Druggists ( AIOCD ), representing over 12.40 lakh chemists across India, has expressed grave concern over the illegal and unregulated operation of online pharmacy platforms, which allegedly continue to sell medicines in violation of the Drugs & Cosmetics Act, 1940, posing a serious threat to public health . Accoridng to a statement from AIOCD, JS Shinde, President, Rajiv Singhal, General Secretary, informed that in a formal communication addressed to the Minister of State for Health and Family Welfare, Anupriya Patel, AIOCD has highlighted the continued inaction by State Licensing Authorities (SLAs), despite repeated complaints being forwarded to them by the Central Drugs Standard Control Organisation ( CDSCO ). Explore courses from Top Institutes in Please select course: Select a Course Category Degree PGDM Operations Management MCA Data Science CXO healthcare MBA Technology Management Data Science Project Management Healthcare Cybersecurity Finance Data Analytics Leadership Design Thinking Others Artificial Intelligence others Digital Marketing Product Management Public Policy Skills you'll gain: Data-Driven Decision-Making Strategic Leadership and Transformation Global Business Acumen Comprehensive Business Expertise Duration: 2 Years University of Western Australia UWA Global MBA Starts on Jun 28, 2024 Get Details While the Minister's reply in the Rajya Sabha on 22nd July 2025 stated that complaints regarding unauthorised sale of medicines are referred to SLAs, however, AIOCD has informed that no visible or effective action has been taken by any SLA across the country. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Play War Thunder now for free War Thunder Play Now Undo To escalate this matter further, a high-level delegation of AIOCD met with the Drug Controller General of India (DCGI), Dr Rajeev Raghuvanshi, on July 21, and urged him to take the following urgent actions: Immediate crackdown on all illegal e-pharmacies operating without any valid license or oversight, including the Quick Commerce Players; Withdrawal of GSR 220(E), which was issued during the COVID-19 epidemic but is now being misused by these platforms to justify unlawful activities, and Withdrawal of GSR 817(E), the draft regulation issued in August 2018, which has remained in draft form for over eight years, enabling misuse due to lack of legal clarity, according to the statement. AIOCD has repeatedly submitted that GSR 817(E) is outdated and has failed to address the ground realities of digital drug distribution. Live Events JS Shinde, President, Rajiv Singhal, General Secretary, AIOCD, highlighted that the loosely drafted definition of 'Manufacturer' is the root cause of the issue and emphasised the need for a holistic and comprehensive approach involving all concerned departments, the statement said. AIOCD also expressed its readiness to provide suitable amendments to the Act, Rules, and relevant orders. AIOCD reiterated that medicines are not ordinary consumer goods, and their sale and distribution must not be left to automated platforms or unauthorized logistics chains. Continued inaction will lead to a public health disaster of irreversible scale. According to the statement, AIOCD demanded immediate withdrawal of GSR 817(E) and GSR 220(E) to prevent further legal misuse; Centralized enforcement action by CDSCO against all illegal online pharmacies; Action of all illegal E pharmacies on government directives must be initiated immediately by State SLA's . AIOCD appeals to the Ministry of Health and Family Welfare to take urgent action in the interest of safeguarding public health and restoring trust in India's pharmaceutical regulatory system, the statement added.
New Indian Express
7 hours ago
- New Indian Express
Hyderabad to get disease surveillance unit soon to boost epidemic preparedness
HYDERABAD: A Metropolitan Surveillance Unit (MSU), a special facility equipped to monitor and analyse disease patterns in urban areas, is set to become operational in Hyderabad within the next two months. Approved by the Ministry of Health and Family Welfare (MoH&FW) under the National Centre for Disease Control (NCDC), the MSU will enhance the city's preparedness for disease outbreaks, drawing from lessons learned during the Covid-19 pandemic. The MSU will function as a specialised disease surveillance hub, conducting advanced diagnostic testing for communicable diseases and issuing alerts for potential outbreaks. It will not handle routine lab testing but will focus on diseases listed under the Integrated Disease Surveillance Programme (IDSP), including anthrax, chickenpox, diphtheria, measles, meningitis, mumps, pertussis, Ebola, Zika, Nipah and yellow fever, among others. GHMC officials told TNIE that the MSU will serve as a crucial node for surveillance, early warning and rapid response to outbreaks. 'The objective is to strengthen urban public health systems by enabling data-driven action. MSUs will be the first line of defence in identifying and containing future epidemics,' they said.
Economic Times
9 hours ago
- Economic Times
Study estimates over 9% of world's lands at high risk of animal-to-human infections
Over nine per cent of the world's land area is at "high" or "very high" risk of a zoonotic outbreak -- triggered when an infection spreads from an animal to a human or vice versa, such as the Covid pandemic, according to a published in the journal Science Advances also estimate 3 per cent of the global population to be living in extremely risky areas, and about a fifth in medium-risk areas. Researchers, including those from the European Commission's Joint Research Centre (JRC) Scientific Development Programmes Unit in Italy, analysed location-specific information from the 'Global Infectious Diseases and Epidemiology Network' dataset and the World Health Organization's (WHO) list of diseases prioritised according to their potential for causing an epidemic or a Ebola, coronavirus-related MERS and SARS, and Nipah are among the most prioritised infections in the WHO's team's analysis suggests that conditions driven by climate change -- higher temperatures and rainfall, and water shortage -- elevate the risk of zoonosis, or 'spillover events'. The study "presents a global risk map and an epidemic risk index that combines countries' specific risk with their capacities for preparing and responding to zoonotic threats (excluding SARS-CoV-2)." "Our results indicate that 9.3 per cent of the global land surface is at high (6.3 per cent) or very high (three per cent) risk," the authors also estimated about 7 per cent of Asia's and 5 per cent of Africa's land area to be at high and very high risk of outbreak, following Latin America (27 per cent) and Oceania (18.6 per cent).Overall, the authors found that climate-related changes to the environment substantially drove a region's vulnerability to the risk of a spillover wrote, "This underscores the need for continued monitoring and the integration of climate adaptation and mitigation efforts into public health planning." "Translating these risk estimates into an epidemic risk index allows for the identification of high-risk areas and supports policymakers in improving response capacities, allocating resources effectively, and fostering international collaboration to address global health threats," the team said. A study by the Indian Council of Medical Research found that over 8 per cent of outbreaks reported between 2018 and 2023 under the country's infectious disease surveillance system were zoonotic. Of a total of 6,948 outbreaks analysed, 583 (8.3 per cent) were spread to humans from animals. Outbreaks were also found to consistently peak during June, July, and August. The findings were published in The Lancet Regional Southeast Asia journal in May this year.
